project id: TCGA-HNSC; case submitter id: TCGA-QK-A8Z9; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 7.6; age at index: 56; days to birth: -20471; days to death: 449; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1957; age at diagnosis: 20471; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 352.0; icd 10 code: C04.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Floor of mouth, NOS; synchronous malignancy: No; tissue or organ of origin: Floor of mouth, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.917808219178082; pack years smoked: 35.0; is ffpe: false; composition: Not Reported; days to collection: 44; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-QK-A8Z9-01B-11; percent lymphocyte infiltration: 18.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 60.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;